HUT77611A - Eljárás dózisegységek előállítására nedves granulálással - Google Patents

Eljárás dózisegységek előállítására nedves granulálással

Info

Publication number
HUT77611A
HUT77611A HU9800154A HU9800154A HUT77611A HU T77611 A HUT77611 A HU T77611A HU 9800154 A HU9800154 A HU 9800154A HU 9800154 A HU9800154 A HU 9800154A HU T77611 A HUT77611 A HU T77611A
Authority
HU
Hungary
Prior art keywords
pct
dosage units
wet granulation
date
sec
Prior art date
Application number
HU9800154A
Other languages
English (en)
Other versions
HU226619B1 (en
Inventor
Jocominus Antonius Maria Zwinkels
Pieter De Haan
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of HUT77611A publication Critical patent/HUT77611A/hu
Publication of HU226619B1 publication Critical patent/HU226619B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU9800154A 1994-09-22 1995-09-19 Process of making dosage units containing at least one progestogen by wet granulation HU226619B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94202728 1994-09-22
PCT/EP1995/003692 WO1996009056A1 (en) 1994-09-22 1995-09-19 Process of making dosage units by wet granulation

Publications (2)

Publication Number Publication Date
HUT77611A true HUT77611A (hu) 1998-06-29
HU226619B1 HU226619B1 (en) 2009-04-28

Family

ID=8217217

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9800154A HU226619B1 (en) 1994-09-22 1995-09-19 Process of making dosage units containing at least one progestogen by wet granulation

Country Status (22)

Country Link
US (1) US5916593A (hu)
EP (1) EP0782449B1 (hu)
JP (1) JP4334616B2 (hu)
KR (1) KR100384264B1 (hu)
CN (1) CN1101681C (hu)
AT (1) ATE236639T1 (hu)
AU (1) AU700645B2 (hu)
BR (1) BR9509019B1 (hu)
CA (1) CA2200754C (hu)
CZ (1) CZ289081B6 (hu)
DE (1) DE69530308T2 (hu)
DK (1) DK0782449T3 (hu)
ES (1) ES2196079T3 (hu)
FI (1) FI118791B (hu)
HU (1) HU226619B1 (hu)
MX (1) MX9702162A (hu)
NO (1) NO311492B1 (hu)
NZ (1) NZ293606A (hu)
PL (1) PL181406B1 (hu)
PT (1) PT782449E (hu)
RU (1) RU2166936C2 (hu)
WO (1) WO1996009056A1 (hu)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0955048A1 (en) * 1998-03-12 1999-11-10 Akzo Nobel N.V. Making dosage units using low shear granulation
IL128818A0 (en) * 1998-03-12 2000-01-31 Akzo Nobel Nv Making dosage units using low shear granulation
WO2000050041A1 (en) * 1999-02-24 2000-08-31 Akzo Nobel N.V. Pharmaceutical compositions containing a crystalline form of the progestagen-(17alpha)-17-hydroxy-11-methylene-19-nor-pregna-4,15-dien-20-yn-3-one (org 30659) and lactose
DK1380301T3 (da) * 1999-08-31 2009-04-20 Bayer Schering Pharma Ag Farmaceutisk sammensætning af ethinylestradiol og drospirenon til anvendelse som svangerskabsforebyggende middel
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
EP1216713A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions of estrogen-cyclodextrin complexes
US20030027848A1 (en) * 2001-06-15 2003-02-06 Anne Billotte Stabilized formulations
PT1275377E (pt) * 2001-07-11 2003-11-28 Fidia Farmaceutici Granulados contendo substancias lipossoluveis e sua preparacao
DE10159120B4 (de) * 2001-12-01 2006-08-17 Lts Lohmann Therapie-Systeme Ag Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung
GB0209265D0 (en) * 2002-04-23 2002-06-05 Novartis Ag Organic compounds
TW200403075A (en) * 2002-05-29 2004-03-01 Akzo Nobel Nv Progestagenic dosage units
ES2530791T3 (es) 2002-12-20 2015-03-05 Hoffmann La Roche Formulación de ibandronato de altas dosis
RU2228747C1 (ru) * 2003-03-03 2004-05-20 Открытое акционерное общество "Щелковский витаминный завод" Антиангинальное средство пролонгированного действия
CZ298224B6 (cs) * 2003-04-29 2007-07-25 Pliva Istrazivanje I Razvoj D.O.O. Farmaceutická kompozice obsahující jako úcinnou látku ribavirin a zpusob její výroby
ES2933479T3 (es) * 2003-09-29 2023-02-09 Novo Nordisk Healthcare Ag Estabilidad mejorada de formulaciones de progestágenos
ES2482104T3 (es) * 2003-09-29 2014-08-01 Novo Nordisk Femcare Ag Formulaciones HRT
JP4412963B2 (ja) * 2003-10-10 2010-02-10 旭有機材工業株式会社 バルブ用樹脂製部材
EP1734930A2 (en) * 2004-04-09 2006-12-27 Smithkline Beecham Corporation Low dose pharmaceutical products
US7846466B2 (en) * 2004-06-10 2010-12-07 Northwestern University Biodegradable scaffolds and uses thereof
KR20070072888A (ko) * 2004-10-25 2007-07-06 니뽄 다바코 산교 가부시키가이샤 용해성 및 안정성이 개선된 고형 제제 및 그의 제조 방법
AU2006206359B2 (en) * 2005-01-21 2011-03-31 Allergan Pharmaceuticals International Limited A tetracycline metal complex in a solid dosage form
CA2598762A1 (en) * 2005-02-25 2006-08-31 F. Hoffmann-La Roche Ag Tablets with improved drug substance dispersibility
CN101489563A (zh) 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
US20090269403A1 (en) * 2008-04-24 2009-10-29 Shaked Ze Ev Oral contraceptive dosage forms and methods of making such dosage forms
EP2328558A2 (en) * 2008-08-08 2011-06-08 McNeil-PPC, Inc. Use of sucralose as a granulating agent
PL2349220T3 (pl) * 2008-10-09 2012-12-31 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Zastosowanie rozpuszczalników organicznych w granulacji na mokro moksyfloksacyny
US8945616B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
US8945615B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
JP2017001989A (ja) * 2015-06-11 2017-01-05 ニプロ株式会社 医薬組成物の製造方法及び医薬組成物
JP6759478B2 (ja) * 2019-02-13 2020-09-23 富士製薬工業株式会社 経口固形組成物、その製造方法、及びその製造方法によって得られた経口用錠剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969502A (en) * 1972-04-14 1976-07-13 Schering Aktiengesellschaft Method for contraception by the administration of sequential contraceptive preparations
GB2192128A (en) * 1986-07-03 1988-01-06 Fa Ez Khan Production of pharmaceutical unit dosage forms
US4956182A (en) * 1989-03-16 1990-09-11 Bristol-Myers Company Direct compression cholestyramine tablet and solvent-free coating therefor
US5098714A (en) * 1989-11-16 1992-03-24 Alza Corporation Osmotic, oral dosage form for fertility control
US5200197A (en) * 1989-11-16 1993-04-06 Alza Corporation Contraceptive pill
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
IE62665B1 (en) * 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
DE4229820C2 (de) * 1992-09-07 1998-12-03 Jenapharm Gmbh Pharmazeutische Zubereitung auf Gestagen-Basis
CA2151260A1 (en) * 1993-02-23 1994-09-01 Warner-Lambert Company A process for the preparation of substantially alcohol free pharmaceutical compositions
EP0613687B1 (en) * 1993-03-05 1999-06-02 Akzo Nobel N.V. Use of a pregnane derivatives for the treatment of tumours
NL9301562A (nl) * 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.

Also Published As

Publication number Publication date
KR970706001A (ko) 1997-11-03
FI118791B (fi) 2008-03-31
JPH10505846A (ja) 1998-06-09
DE69530308T2 (de) 2003-10-16
CN1161650A (zh) 1997-10-08
CN1101681C (zh) 2003-02-19
EP0782449B1 (en) 2003-04-09
US5916593A (en) 1999-06-29
KR100384264B1 (ko) 2003-08-30
NO311492B1 (no) 2001-12-03
CZ89997A3 (en) 1997-09-17
BR9509019A (pt) 1997-12-30
RU2166936C2 (ru) 2001-05-20
PT782449E (pt) 2003-07-31
ATE236639T1 (de) 2003-04-15
DE69530308D1 (de) 2003-05-15
PL181406B1 (pl) 2001-07-31
PL319373A1 (en) 1997-08-04
CZ289081B6 (cs) 2001-10-17
NO971361D0 (no) 1997-03-21
CA2200754C (en) 2008-04-15
DK0782449T3 (da) 2003-08-04
EP0782449A1 (en) 1997-07-09
NO971361L (no) 1997-05-21
AU700645B2 (en) 1999-01-14
HK1002172A1 (en) 1998-08-07
JP4334616B2 (ja) 2009-09-30
FI971172L (fi) 1997-03-20
FI971172A0 (fi) 1997-03-20
NZ293606A (en) 1998-06-26
WO1996009056A1 (en) 1996-03-28
BR9509019B1 (pt) 2009-01-13
AU3608295A (en) 1996-04-09
MX9702162A (es) 1997-06-28
CA2200754A1 (en) 1996-03-28
ES2196079T3 (es) 2003-12-16
HU226619B1 (en) 2009-04-28

Similar Documents

Publication Publication Date Title
NO971361D0 (no) Fremgangsmåte for fremstilling av doseringsenheter ved våtgranulering
IL116083A (en) Liquid pharmaceutical compositions containing ondanseteron and sorbitol as sweetener
ATE260646T1 (de) Schnell zerfallende orale dosierungsform
ATE237330T1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
DK0758241T3 (da) Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser
AU3254395A (en) Use of a combination product that contains a competitive progesterone antagonist and a gestagen for the production of a pharmaceutical agent for treating endometriosis or leiomyomata uteri
NO994275L (no) Nikotinsyrepreparater til behandling av hyperlipidemi og tilknyttede fremgangsmaater
SE9401728D0 (sv) New compounds II
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
ES2013342A6 (es) Procedimiento para preparar composiciones farmaceuticas a base de ingredientes seleccionados principalmente entre alcohol, fenol, polvo de cantarida, yodo y fosforo.
RU96111879A (ru) Способ приготовления гомеопатических мягких лекарственных форм

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: N.V. ORGANON, NL

Free format text: FORMER OWNER(S): AKZO NOBEL N.V., NL

MM4A Lapse of definitive patent protection due to non-payment of fees